Warberg Asset Management LLC Baudax Bio, Inc. Transaction History

Warberg Asset Management LLC

  • $21.3 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$0.26 - $0.87 $61,230 - $204,885
235,500 Added 682.61%
270,000 $66,000
Q1 2022

May 13, 2022
BUY
$1.58 - $8.47 $54,510 - $292,215
34,500 New
34,500 $61,000

About Baudax Bio, Inc.

BXRX Quotes by TradingView
  • Ticker BXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,003,700
  • Market Cap $200K
  • Description
  • Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuro...
More about BXRX
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email